{"id":474855,"date":"2020-03-19T02:34:01","date_gmt":"2020-03-19T02:34:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=474855"},"modified":"2020-03-19T02:34:01","modified_gmt":"2020-03-19T02:34:01","slug":"hypercholesterolemia-market-insights-epidemiology-and-market-forecast2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/hypercholesterolemia-market-insights-epidemiology-and-market-forecast2030_474855.html","title":{"rendered":"Hypercholesterolemia – Market Insights, Epidemiology, and Market Forecast – 2030"},"content":{"rendered":"
\"Hypercholesterolemia<\/a><\/div>\n
DelveInsight’s “Hypercholesterolemia – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Hypercholesterolemia, historical and forecasted epidemiology as well as the Hypercholesterolemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<\/div>\n

DelveInsight<\/strong> launched its new report on Hypercholesterolemia – Market Insights, Epidemiology, and Market Forecast-2030<\/a>.<\/p>\n

DelveInsight’s “Hypercholesterolemia – Market Insights, Epidemiology, and Market Forecast-2030<\/strong>“<\/span> report delivers an in-depth understanding of the Hypercholesterolemia, historical and forecasted epidemiology as well as the Hypercholesterolemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

Some key facts of the report:<\/strong><\/p>\n

More than 34 million American adults have increased blood cholesterol levels (i.e. higher than 240 mg\/dL).<\/span>
<\/span><\/p>\n

Key benefits of the report:<\/strong><\/p>\n

1. Hypercholesterolemia market report covers a descriptive overview and comprehensive insight of the Hypercholesterolemia epidemiology and Hypercholesterolemia market in the 7 MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)<\/span>
2. Hypercholesterolemia market report provides insights into current and emerging therapies.<\/span>
3. Hypercholesterolemia market report provides a global historical and forecasted market covering drug outreach in 7 MM.<\/span>
4. Hypercholesterolemia market report offers an edge that will help in developing business strategies by understanding trends shaping and leading the Hypercholesterolemia market.<\/span><\/span><\/p>\n

Request for sample pages<\/strong>: https:\/\/www.delveinsight.com\/sample-request\/hypercholesterolemia-market<\/span><\/span><\/p>\n

\"\"<\/span><\/span><\/p>\n

Hypercholesterolemia<\/strong> is the most commonly occurring disorder, which results in comorbid conditions, mainly cardiovascular disorders. High levels of low-density lipoprotein (LDL) cholesterol results into an accumulation of cholesterol-rich fatty deposits in arteries resulting in a narrow or blocked flow of blood to vital organs, especially the heart and brain. <\/span><\/span><\/span><\/p>\n

The Hypercholesterolemia treatment paradigm, which further includes sub-types, such as Homozygous and Heterozygous Familial Hypercholesterolemia holds several options available in the market, i.e., statins, bile-acid-binding resins, cholesterol absorption inhibitors, combination cholesterol absorption inhibitor with statin and Proprotein Convertase Subtilisin\/Kexin Type 9 (PCSK9) inhibitors as well as Injectable medications.<\/span><\/span><\/span><\/p>\n

Key pharma players involved in Hypercholesterolemia market are:<\/strong><\/p>\n

1. Innovent Biologics
2. Esperion
3. Regeneron Pharmaceuticals
4. Akcea Therapeutics
5. Ionis Pharmaceuticals<\/span><\/span><\/span><\/span><\/p>\n

Drugs covered are:<\/strong>
1. IBI306<\/span>
2. Bempedoic Acid<\/span>
3. AKCEA-ANGPTL3-LRX<\/span>
4. Evinacumab<\/span><\/p>\n

Table of contents:<\/strong>
1. Report Introduction<\/span>
2. Hypercholesterolemia Market Overview at a Glance<\/span>
3. Hypercholesterolemia Disease Background and Overview<\/span>
4. Hypercholesterolemia Epidemiology and Patient Population (7MM)<\/span>
5. Hypercholesterolemia Country-Wise Epidemiology<\/span>
5.1. United States<\/span>
5.2. EU5 Countries<\/span>
5.3. Germany<\/span>
5.4. France<\/span>
5.5. Italy<\/span>
5.6. Spain<\/span>
5.7. United Kingdom<\/span>
5.8. Japan<\/span>
6. Hypercholesterolemia Treatments and Medical Practices<\/span>
7. Hypercholesterolemia Current Treatment<\/span>
7.1. Repatha: Amgen<\/span>
7.2. Praluent: Sanofi<\/span>
7.3. Lipitor: Pfizer<\/span>
8. Hypercholesterolemia Emerging Therapies<\/span>
8.1. Key Cross Competition<\/span>
8.2. IBI306: Innovent Biologics<\/span>
8.3. Bempedoic Acid: Esperion<\/span>
8.4. Evinacumab: Regeneron Pharmaceuticals<\/span>
8.5. AKCEA-ANGPTL3-LRX: Akcea Therapeutics\/Ionis Pharmaceuticals<\/span>
9. Hypercholesterolemia Market Size<\/span>
10. Hypercholesterolemia 7MM Country-Wise Market Analysis<\/span>
11. United States Market Size<\/span>
12. EU5 Market Size<\/span>
12.1. Germany Market Size<\/span>
12.2. France Market Size<\/span>
12.3. Italy Market Size<\/span>
12.4. Spain Market Size<\/span>
12.5. United Kingdom Market Size<\/span>
13. Japan Market Size<\/span>
14. Market Drivers<\/span>
15. Market Barriers<\/span>
16. Report Methodology<\/span>
17. DelveInsight Capabilities<\/span>
18. Disclaimer<\/span>
19. About DelveInsight<\/strong><\/span>
<\/span><\/span><\/span><\/p>\n

Related reports:<\/strong><\/span><\/span><\/span><\/span><\/p>\n

Hypercholesterolemia – Epidemiology Forecast to 2030<\/span><\/a><\/p>\n

Hypercholesterolemia Pipeline Insight, 2020<\/span>
<\/a><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> DelveInsight Business Research LLP<\/a>
Contact Person:<\/strong> Yash Bhardwaj
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 9193216187
Address:<\/strong>304 S. Jones Blvd #2432
City:<\/strong> Las Vegas
State:<\/strong> Nevada
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.delveinsight.com\/<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

DelveInsight’s “Hypercholesterolemia – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Hypercholesterolemia, historical and forecasted epidemiology as well as the Hypercholesterolemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-474855","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/474855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=474855"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/474855\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=474855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=474855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=474855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}